New Zealand Clinical Research (NZCR) is New Zealand’s leading clinical trials and medical research organisation, with over 25 years of research experience and a track record of completing over 800 trials involving over 17,000 New Zealanders.

They are currently looking for people to take part in a clinical trial who are:

• Aged 18–60 years
• Diagnosed with IgA Nephropathy (IgAN), confirmed by kidney biopsy within the last 5 years
• Taking stable doses of an ACE inhibitor or angiotensin receptor blocker, such as Lisinopril, Enalapril, Losartan or Valsartan

By taking part in clinical research, you could help contribute to the development of potential future treatments for people living with IgAN.

Clinical trials involve an investigational medicine and study assessments. Eligibility criteria apply. Register your interest today to find out more, or share with someone who may be a good candidate.

To find out more, please visit: https://www.nzcr.co.nz/trial/juniper/

The University of Sydney are conducting an interview study on health behaviours and substance use. The study aims to understand the perspectives of people with chronic kidney disease (CKD) on health behaviours and substance use. 

University of Sydney want to understand the perspectives and experiences of substance use, as well as preferences for support and interventions for people with CKD.

If you are interested and available to participate or have any questions, please email Anastasia at anastasia.hughes@sydney.edu.au

IMPEDE-PKD or Implementation of Metformin theraPy to Ease DEcline of kidney function in PKD (IMPEDE-PKD)

The IMPEDE-PKD research study (also known as a clinical trial) is testing whether metformin, a medicine used for diabetes and other conditions, can slow the decrease in kidney function for people with Autosomal Dominant Polycystic Kidney Disease.

The trial is being conducted in New Zealand, Australia, India, and the UK.

Please visit https://kidneytrials.com/trials/impede-pkd/ for contact information.